within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AB08_InterferonBeta1b;

model InterferonBeta1b
  extends Pharmacolibrary.Drugs.ATC.L.L03AB08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>InterferonBeta1b</td></tr><tr><td>ATC code:</td><td>L03AB08</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Interferon beta-1b is a recombinant form of human interferon beta used as an immunomodulatory agent in the treatment of relapsing forms of multiple sclerosis (MS). It functions by modifying the immune response and reducing inflammation. Interferon beta-1b is an FDA- and EMA-approved medication that has been in clinical use for MS for several decades.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following subcutaneous administration of 250 micrograms in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Connelly, JF (1994). Interferon beta for multiple sclerosis. <i>The Annals of pharmacotherapy</i> 28(5) 610–616. DOI:<a href=\"https://doi.org/10.1177/106002809402800511\">10.1177/106002809402800511</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8069001/\">https://pubmed.ncbi.nlm.nih.gov/8069001</a></p></li><li><p>Johnston, J, &amp; So, TY (2012). First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview. <i>Drugs</i> 72(9) 1195–1211. DOI:<a href=\"https://doi.org/10.2165/11634010-000000000-00000\">10.2165/11634010-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22642799/\">https://pubmed.ncbi.nlm.nih.gov/22642799</a></p></li><li><p>Scott, LJ (2013). Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis. <i>CNS drugs</i> 27(11) 971–988. DOI:<a href=\"https://doi.org/10.1007/s40263-013-0117-3\">10.1007/s40263-013-0117-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24129744/\">https://pubmed.ncbi.nlm.nih.gov/24129744</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InterferonBeta1b;
